Concomitant treatment of neuroleptic malignant syndrome and psychosis.
Two cases are presented in which psychotic patients with neuroleptic malignant syndrome were treated with bromocriptine and thioridazine simultaneously, with a resulting control of both problems. The authors feel that this method needs further study, in the light of the potentially large number of patients at risk for these illnesses. The use of creatinine phosphokinase level as an indicator of value in NMS is also discussed.
University of North Carolina.
H D
HD
Goldwasser
J F
JF
Hooper
N M
NM
Spears
D000328:Adult; D001971:Bromocriptine / Q000627:therapeutic use; D003402:Creatine Kinase / Q000097:blood; D006801:Humans; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000150:complications / Q000188:drug therapy* / Q000201:enzymology; D011618:Psychotic Disorders / Q000150:complications / Q000188:drug therapy*; D013881:Thioridazine / Q000627:therapeutic use
D001971:Bromocriptine; D003402:Creatine Kinase; D013881:Thioridazine